Corticosteroids as adjunctive therapy for diffuse alveolar hemorrhage associated with bone marrow transplantation. University of Nebraska Medical Center Bone Marrow Transplant Group.

[1]  J. Wingard.  Infectious complications of bone‐marrow transplantation , 1995 .

[2]  J. L. Goodman,et al.  A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. , 1992, The New England journal of medicine.

[3]  N. Müller,et al.  Diffuse pulmonary hemorrhage. , 1991, Radiologic clinics of North America.

[4]  J. Karp,et al.  Strategies to prevent or control infections after bone marrow transplants. , 1991, Bone marrow transplantation.

[5]  S. Horning,et al.  Corticosteroid therapy for diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. , 1991, Annals of internal medicine.

[6]  M. Ratajczak,et al.  [Pulmonary complications of bone marrow transplantation]. , 1991, Polski tygodnik lekarski.

[7]  S. Rennard,et al.  Pulmonary surveillance using bronchoscopy and bronchoalveolar lavage during high-dose antineoplastic therapy. , 1991, Chest.

[8]  Meyers Jd.  Fungal infections in bone marrow transplant patients. , 1990 .

[9]  D. Snyder,et al.  Treatment of chronic myelogenous leukemia with bone marrow transplantation. , 1990, Hematology/oncology clinics of North America.

[10]  R. Hyland,et al.  Pulmonary complications following bone marrow transplantation. , 1990, Clinics in chest medicine.

[11]  R. Storb,et al.  Treatment of aplastic anemia. , 1990, Hematology/oncology clinics of North America.

[12]  R. Soejima,et al.  Hydrocortisone inhibits the respiratory burst oxidase from human neutrophils in whole-cell and cell-free systems. , 1990, Biochimica et biophysica acta.

[13]  O. Ringdén,et al.  Which bone marrow transplant recipients are at risk of acquiring life-threatening fungal infections? , 1990, Transplantation proceedings.

[14]  S. Rennard,et al.  Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis. , 1990, The Journal of laboratory and clinical medicine.

[15]  J. Armitage,et al.  Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. , 1991, The American journal of medicine.

[16]  O. Ringdén,et al.  Variables predicting deep fungal infections in bone marrow transplant recipients. , 1989, Bone marrow transplantation.

[17]  A. Stuck,et al.  Risk of infectious complications in patients taking glucocorticosteroids. , 1989, Reviews of infectious diseases.

[18]  T. Ahmed,et al.  High-dose, potentially myeloablative chemotherapy and autologous bone marrow transplantation for patients with advanced Hodgkin's disease. , 1989, Leukemia.

[19]  S. Rennard,et al.  Assessment of airways inflammation utilizing bronchoalveolar lavage. , 1988, Clinics in chest medicine.

[20]  S. Crawford,et al.  Open lung biopsy diagnosis of diffuse pulmonary infiltrates after marrow transplantation. , 1988, Chest.

[21]  K. Petroni,et al.  Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated functions by IFN-gamma and glucocorticoids. , 1988, Journal of immunology.

[22]  A. Berger,et al.  Development, testing, and application of the oral assessment guide. , 1988, Oncology nursing forum.

[23]  R. Matthay,et al.  Drug-induced pulmonary disease. , 2015, Disease-a-month : DM.

[24]  W. Travis,et al.  Diffuse Pulmonary Hemorrhage: An Uncommon Manifestation of Wegener's Granulomatosis , 1987, The American journal of surgical pathology.

[25]  K. Anderson,et al.  Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis. , 1987, The New England journal of medicine.

[26]  J. Armitage,et al.  High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. , 1987, The New England journal of medicine.

[27]  P. Bierling,et al.  Pulmonary complications occurring after allogeneic bone marrow transplantation. A study of 130 consecutive transplanted patients , 1986, Cancer.

[28]  R. Matthay,et al.  Drug-induced pulmonary disease. Part 2: Noncytotoxic drugs. , 1986, The American review of respiratory disease.

[29]  R. Matthay,et al.  Drug-induced pulmonary disease. Part 1: Cytotoxic drugs. , 1986, The American review of respiratory disease.

[30]  J. Hermans,et al.  Bone marrow transplantation for acute nonlymphoblastic leukaemia: a survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.) , 1984, British journal of haematology.

[31]  R. Dinsmore,et al.  Allogeneic bone marrow transplantation for patients with acute nonlymphocytic leukemia. , 1984, Blood.

[32]  J. Watson,et al.  Problems of infection after bone marrow transplantation. , 1983, Journal of clinical pathology.

[33]  L. Pertschuk,et al.  Pulmonary hemorrhage in systemic lupus erythematosus. , 1981, Archives of internal medicine.

[34]  K. E. Holley,et al.  Use of combined plasmapheresis and immunosuppression in the treatment of Goodpasture's syndrome. , 1979, Mayo Clinic proceedings.

[35]  C. Wilson,et al.  Antiglomerular Basement Membrane Antibody‐Mediated Glomerulonephritis and Goodpasture's Syndrome , 1979, Medicine.

[36]  C. Wilson,et al.  Plasmapheresis and immunosuppressive agents in antibasement membrane antibody-induced Goodpasture's syndrome. , 1978, The American journal of medicine.

[37]  P. Neiman,et al.  One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. , 1977, Blood.

[38]  N. Gross.  Pulmonary effects of radiation therapy. , 1977, Annals of internal medicine.

[39]  R. Schrier,et al.  Serious pulmonary hemorrhage, glomerulonephritis, and massive steroid therapy. , 1975, Annals of internal medicine.